Nureca P/B Ratio
Nureca (NURECA) P/B ratio is 1.24 (Moderate), book value per share ₹194.00 vs Healthcare average P/B of -0.3 — Moderate - Reasonably valued relative to book value. View NURECA price range for the annual high/low range and current price position.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
NURECA P/B Ratio — Valuation Insights & Book Value Analysis
Nureca price-to-book ratio interpretation, valuation status and historical context — current P/B 1.24 (Moderate). Review NURECA P/E ratio to evaluate earnings-based valuation against sector peers.
- Current PB is 69.0% below historical average
- Trading at premium to sector average PB of -0.3
Nureca P/B Ratio Historical Trend
NURECA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see NURECA screener.
NURECA Historical P/B Ratio — Book Value Per Share & Year-End Price
Nureca annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 1.59 | ₹194.0 | ₹307.95 | ₹194 | Moderate |
| 2024 | 1.47 | ₹193.0 | ₹282.95 | ₹193 | Moderate |
| 2023 | 2.19 | ₹195.0 | ₹427.90 | ₹195 | Moderate |
| 2022 | 2.45 | ₹203.0 | ₹498.15 | ₹203 | Moderate |
| 2021 | 12.3 | ₹163.0 | ₹2005.00 | ₹163 | High |
NURECA vs Healthcare Peers — P/B Ratio Comparison
Nureca P/B 1.24 vs Healthcare average -0.3, median 0.6 — range -16.4–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -16.4 | ₹20 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.23 | ₹73 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹126 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |